TITLE

Exceeding Surgical Expectations

PUB. DATE
March 2011
SOURCE
Review of Ophthalmology;Mar2011, Vol. 18 Issue 3, following p10
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents statements from several ophthalmologists regarding clinical results and experiences with ophthalmology instruments and intraocular lenses (IOLs). Dr. Cathleen M. McCabe mentions their use of Stellaris Vision Enhancement System from Bausch & Lomb Inc. to handle higher vacuums with microincision cataract surgery (MICS). Dr. Boris Malyugin shares his experience in using the Akreos M160 IOL during a coaxial MICS. Jay S. Pepose shares the factors that affect IOL performance.
ACCESSION #
59571782

 

Related Articles

  • Dispersive-cohesive OVD performs well during all stages of lens removal, says surgeon. Hunkeler, John D. // Ophthalmology Times;8/15/2009, Vol. 34 Issue 16, p18 

    The article discusses a study which found that the ophthalmic viscosurgical device (OVD) of 1.6 percent sodium hyaluronate is superior compare to another OVD in phacoemulsification. The study assessed the performance of two different OVDs during a cataract removal processes and reinforced...

  • Dual aspiration pump system provides high flexibility. Guttman, Cheryl; Devine, Terence M.; Koch, Douglas A. // Ophthalmology Times;01/01/2000, Vol. 25 Issue 1, p16 

    Provides information on the Concentrix dual aspiration pump system available from Bausch & Lomb Surgical's Millennium Microsurgical system for cataract surgeons. Benefits of the dual aspiration pump; User interface of the dual aspiration pump; Features and capabilities.

  • Simplicity of instrument design yields complete package. Charters, Lynda; Daevgan, Uday // Ophthalmology Times;9/15/2008, Vol. 33 Issue 18, p37 

    The article evaluates the Devgan Cataract Set from Bausch & Lomb Inc.

  • Implant Offers an Alternative to Steroids.  // Review of Ophthalmology;Jun2000, Vol. 7 Issue 6, p10 

    Introduces Envision TD, an intraocular implant used in the treatment of severe uveitis developed by Plans of Bausch & Lomb in the United States. Plans of the company to start the phase III clinical trials of the technology; Improvement of the Phase II trial; Business strategy for the promotion...

  • Users find burst mode power affords numerous advantages. Guttman, Cheryl // Ophthalmology Times;2/15/2003, Vol. 28 Issue 4, p18 

    Features the burst mode power modulation by Bausch & Lomb Surgical. Efficiency and safety of phacoemulsification; Application in bimanual surgery; Options provided for surgeons to control the bursting power.

  • B + L voluntarily recalls Murocel solution.  // Optometry Times;Jul/Aug2011, Vol. 3 Issue 7, p8 

    The article reports on Bausch + Lomb's voluntary recall of a single lot of Murocel Methylcellulose Lubricant Ophthalmic Solution, USP 1%, after routine stability testing showed that the single lot was out of specification for preservative efficacy.

  • ReNu Sensitive Eyes.  // Drug Store News;8/10/2009, Vol. 31 Issue 9, p96 

    The article evaluates the ReNu Sensitive Eyes solution from Bausch & Lomb.

  • ReNu Fresh Lens Comfort.  // Drug Store News;8/10/2009, Vol. 31 Issue 9, p98 

    The article evaluates the ReNu Fresh Lens Comfort Multi-Purpose solution from Bausch & Lomb.

  • Test shows reduced glare, halo and starburst after cataract surgery. Hasson, Matt // Ocular Surgery News;4/25/2009, Vol. 27 Issue 8, p20 

    The article focuses on a study which examined the reliability of a device in evaluating glare and halo before and after cataract surgery. According to ophthalmologist Michael Ehrlich, glare tests can be expensive to purchase and time-consuming to perform. A number of patients undergoing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics